Physician profile
Hari Baddigam
NPI 1881629491
$15,376.29
in general payments reported to CMS, 2019-2025
17 companies · $680 in 2025
The $680 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,197 · 2020: $2,492 · 2021: $1,786 · 2022: $1,727 · 2023: $3,922 · 2024: $572 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,164 · Consulting Fee: $1,625 · Travel and Lodging: $1,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,163.57 |
| Consulting Fee | $1,625.00 |
| Travel and Lodging | $1,386.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,161.47 | 2021-2025 | Micra, Linq II, Cobalt Dr Mri Surescan |
| Medtronic Vascular, INC. | $5,883.05 | 2019-2020 | |
| Biosense Webster, INC. | $247.28 | 2019-2020 | |
| Shockwave Medical, INC | $238.70 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $194.90 | 2019-2025 | Watchman, Emblem Mri S-Icd, Ingevity+ |
| Novartis Pharmaceuticals Corporation | $169.19 | 2019-2020 | |
| Abbott Laboratories | $131.49 | 2019-2025 | Aveir, Gallant, Jot Dx |
| Astrazeneca Pharmaceuticals Lp | $108.07 | 2019-2021 | |
| Cardiva Medical, INC. | $67.34 | 2022-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs |
| Amgen INC. | $49.49 | 2019-2025 | Repatha |
| Pfizer INC. | $32.80 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $31.66 | 2020 | |
| Merck Sharp & Dohme LLC | $18.74 | 2021 | |
| Cardiovascular Systems INC. | $13.98 | 2019 | |
| Ethicon US, LLC | $12.59 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $11.59 | 2020 | |
| Elutia, INC. | $3.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hari Baddigam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.